Immunizations: Adult Vaccine Data
- Related Pages
- Immunization Data Home
- Vaccine Preventable Diseases
- Wisconsin Immunization Registry
- Adult Immunizations
Vaccines are one of the most important tools we have to keep people healthy. Each year thousands of adults in the Wisconsin get sick from diseases that could be prevented by vaccines. There are vaccines that are recommended for all adults, and other vaccines that might be recommended based on your age, job, or other aspects of your life.
You can visit the Wisconsin Immunization Registry (WIR) to learn if you are up to date on vaccines. You can also access the CDC's (Centers for Disease Control and Prevention) schedule for adults to learn when different vaccines are recommended.
The data on this webpage shows the vaccination rates of adults and is updated annually. See "Vaccines included in the dashboard" section on this page for more information on vaccines included in the dashboards.
Annual adult vaccination data
This dashboard shows the percent of Wisconsin adults who received the recommended routine vaccinations. The data is by shown sex, race, ethnicity, age category and social vulnerability for each vaccine or vaccine series. These data can be used to identify health disparities and can inform vaccination efforts.
The Social Vulnerability Index (SVI) was created by the CDC and Agency for Toxic Substances and Disease Registry (ATSDR). The index ranks census tracts based on 16 measures, such as percent of people without health insurance, percent of people without a vehicle, and percent of people below 150% poverty.
Individuals living in census tracts with high social vulnerability may experience additional barriers to vaccination. High social vulnerability was defined as individuals living in a census tract that is in the top 25% for vulnerability in Wisconsin. Census tracts designated as high vulnerability would have the highest levels in Wisconsin of the measures included, such as high levels of poverty.
Low social vulnerability was defined as individuals living in a census tract that is in the bottom 25% for vulnerability in Wisconsin. Census tracts with the low social vulnerability have the lowest levels of the measures included, such as low levels of people that are uninsured.
Data source: The Wisconsin Immunization Registry (WIR).
Reporting to WIR is not required for all vaccines given and is only mandatory in certain circumstances.
Vaccines received out of state and vaccines received prior to the implementation of WIR in 2000, may not be in the registry. As a result, immunization histories for adults in WIR may be incomplete for vaccines that could have been received childhood, such as hepatitis A and hepatitis B.
Vaccination Coverage: The number of adults who received the vaccine divided by the number of individuals in that population and multiplied by 100.
Population: Adults in WIR.
Before 2023, individuals who were reported with a non-Wisconsin address and deceased individuals were excluded from our calculation of coverage rates. Starting in 2023, the exclusion criteria was expanded to provide a more accurate population denominator by removing individuals whose records have not had activity for an extended period of time and therefore may no longer reside in Wisconsin. The additional excluded records were clients at least 11 years old, whose records were not updated in at least 10 years, and not queried in at least five years. Due to the change in methodology, data from 2023 and later is not comparable to previous years.
Demographic information, such as sex, race, and ethnicity are not required to be reported. In 2024, for adults, missingness ranged from 8 to 12% for race, 4 to 7% for ethnicity and <1% for sex. At this time, data in WIR is based on sex (male/female) and does not capture gender identity. Additionally, WIR cannot store multiple race variables for an individual.
Social Vulnerability Index (SVI): Census tract social vulnerability data came from the 2022 state-based CDC/ATSDR SVI database. The quartiles were created in alignment with CDC/ATSDR SVI interactive map, where a percentile ranking of 0.7500 to 1.0 was categorized as high vulnerability and a SVI ranking of 0.0 to 0.2500 was categorized as low vulnerability. Each individual was assigned a SVI quartile based off the census tract of their primary address in the year of analysis. To learn more about the social vulnerability, visit the ASTDR and CDC webpage about the index. To learn which census tracts are high and low vulnerability, visit the interactive SVI map.
Adult vaccines
Current vaccination recommendations can be located on the CDC's schedule for adults. To view vaccination recommendations over time, refer to the CDC’s vaccine-specific recommendations webpage.
| Vaccine or vaccine series abbreviation | Definition | ACIP Recommendation |
|---|---|---|
| HPV Complete | 2 or 3 valid doses of human papillomavirus vaccine, depending on age at vaccine series initiation among adults 19–26. Prior to 2017, HPV complete rates reflect a three-dose series. | The HPV vaccine was first licensed in 2006. It is routinely recommended starting at age 9 but is recommended for everyone through age 26. |
| HepA Complete | 1 or more valid doses of hepatitis A vaccine among adults 19–49 years. | The first hepatitis A vaccine was licensed in 1995 and was initially recommended for children in communities with high rates of disease. Starting in 2006 the hepatitis A vaccine was universally recommended for all children age at 12 months of age. The vaccine is also recommended for select adults at high risk of infection or adults who request vaccination. |
| HepB (1) | 1 or more valid doses of hepatitis B vaccine among adults 19–59 years old. | In 1991, all infants were recommended to receive the hepatitis B vaccine. Starting, in 2022, the hepatitis B vaccine was universally recommended for all adults 19–59 years old. |
| HepB Complete | 2 or 3 valid doses of hepatitis B vaccine, depending on trade name, among adults 19–59 years old. | In 1991, all infants were recommended to receive the hepatitis B vaccine. Starting in 2022, the hepatitis B vaccine was universally recommended for all adults 19–59 years old. |
| Td or Tdap | 1 or more valid doses of a tetanus containing vaccine in the past 10 years among adults 19–64 years old. | Starting in 2005, a dose of the Tdap vaccine was recommended for adolescents followed by a Td booster dose every 10 years. In 2019, the recommendation was updated to allow either the Tdap or Td vaccine to be given for booster doses. |
| Tdap | 1 or more valid doses of tetanus-diphtheria-acellular pertussis vaccine in the past 10 years among adults 19–64 years old. | Starting in 2005, a dose of the Tdap vaccine was recommended for adolescents followed by a Td booster dose every 10 years. In 2019, the recommendation was updated to allow either the Tdap or Td vaccine to be given for booster doses. |
| Zoster (Shingles) Complete | 2 or more valid Shingrix vaccine doses among adults 50 years and older. | Starting in 2018, Shingrix was recommended for all adults 50 years and older. |
| Pneumo Complete | 1, 2 or 3 doses valid doses of pneumococcal vaccine, depending on trade name, among adults 65 years and older. This rate reflects completion according to the Advisory Committee on Immunization Practices recommendation as of June 2024. | Starting in October 2024, pneumococcal vaccination was recommended for adults 50 years and older. Prior to, that adults 65 and older were recommended for the PCV vaccine, which is reflected in the dashboard. |
Click the following links to download the data.
For questions about the dashboards or data, email the Immunization Program at DHSImmProgram@dhs.wisconsin.gov
County and regional vaccination rates of adults
This dashboard shows the percent of Wisconsin adults vaccinated for recommended routine vaccinations by county and region for the previous year and over time.
Data source: The Wisconsin Immunization Registry (WIR).
Reporting to WIR is not required for all vaccines given and is only mandatory in certain circumstances.
Vaccines received out of state and vaccines received prior to the implementation of WIR in 2000, may not be in the registry. As a result, immunization histories for adults in WIR may be incomplete for vaccines that could have been received childhood, such as hepatitis A and hepatitis B.
Vaccination Coverage: The number of adults who received the vaccine divided by the number of individuals in that population and multiplied by 100.
Population: Adults in WIR.
Before 2023, individuals who were reported with a non-Wisconsin address and deceased individuals were excluded from our calculation of coverage rates. Starting in 2023, the exclusion criteria was expanded to provide a more accurate population denominator by removing individuals whose records have not had activity for an extended period of time and therefore may no longer reside in Wisconsin. The additional excluded records were clients at least 11 years old, whose records were not updated in at least 10 years, and not queried in at least five years. Due to the change in methodology, data from 2023 and later is not comparable to previous years.
Address information, such as county, is not required to be reported in the WIR. In 2024, county and region information were unknown for < 1% of adults.
Adult vaccines
Current vaccination recommendations can be located on the CDC's schedule for adults. To view vaccination recommendations overtime, refer to the CDC’s vaccine-specific recommendations webpage.
| Vaccine or vaccine series abbreviation | Definition | ACIP Recommendation |
|---|---|---|
| HPV Complete | 2 or 3 valid doses of human papillomavirus vaccine, depending on age at vaccine series initiation among adults 19–26. Prior to 2017, HPV complete rates reflect a 3 dose series. | The HPV vaccine was first licensed in 2006. It is routinely recommended starting at age 9 but is recommended for everyone through age 26. |
| HepA Complete | 1 or more valid doses of hepatitis A vaccine among adults 19–49 years. | The first hepatitis A vaccine was licensed in 1995 and was initially recommended for children in communities with high rates of disease. Starting in 2006 the hepatitis A vaccine was universally recommended for all children age at 12 months of age. The vaccine is also recommended for select adults at high risk of infection or adults who request vaccination. |
| HepB (1) | 1 or more valid doses of hepatitis B vaccine among adults 19–59 years old. | In 1991, all infants were recommended to receive the hepatitis B vaccine. Starting, in 2022, the hepatitis B vaccine was universally recommended for all adults 19–59 years old. |
| HepB Complete | 2 or 3 valid doses of hepatitis B vaccine, depending on trade name, among adults 19–59 years old. | In 1991, all infants were recommended to receive the hepatitis B vaccine. Starting in 2022, the hepatitis B vaccine was universally recommended for all adults 19–59 years old. |
| Td or Tdap | 1 or more valid doses of a tetanus containing vaccine in the past 10 years among adults 19–64 years old. | Starting in 2005, a dose of the Tdap vaccine was recommended for adolescents followed by a Td booster dose every 10 years. In 2019, the recommendation was updated to allow either the Tdap or Td vaccine to be given for booster doses. |
| Tdap | 1 or more valid doses of tetanus-diphtheria-acellular pertussis vaccine in the past 10 years among adults 19–64 years old. | Starting in 2005, a dose of the Tdap vaccine was recommended for adolescents followed by a Td booster dose every 10 years. In 2019, the recommendation was updated to allow either the Tdap or Td vaccine to be given for booster doses. |
| Zoster (Shingles) Complete | 2 or more valid Shingrix vaccine doses among adults 50 years and older. | Starting in 2018, Shingrix was recommended for all adults 50 years and older. |
| Pneumo Complete | 1, 2 or 3 doses valid doses of pneumococcal vaccine, depending on trade name, among adults 65 years and older. This rate reflects completion according to the Advisory Committee on Immunization Practices recommendation as of June 2024. | Starting in October 2024, pneumococcal vaccination was recommended for adults 50 years and older. Prior to, that adults 65 and older were recommended for the PCV vaccine, which is reflected in the dashboard. |
Select the following links to download the data.
For questions about the dashboards or data, email the Immunization program at DHSImmProgram@dhs.wisconsin.gov